Oxysterols from free radical chain oxidation of 7-dehydrocholesterol: product and mechanistic studies. Xu L, Korade Z, Porter NA (2010) J Am Chem Soc 132: 2222-32 Reactivities and products of free radical oxidation of cholestadienols. Xu L, Porter NA (2014) J Am Chem Soc 136: 5443-50 DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model. Xu L, Mirnics K, Bowman AB, Liu W, Da J, Porter NA, Korade Z (2012) Neurobiol Dis 45: 923-9 Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate. Shinkyo R, Xu L, Tallman KA, Cheng Q, Porter NA, Guengerich FP (2011) J Biol Chem 286: 33021-8 Effect of psychotropic drug treatment on sterol metabolism. Korade Ž, Liu W, Warren EB, Armstrong K, Porter NA, Konradi C (2017) Schizophr Res 187: 74-81 A perspective on free radical autoxidation: the physical organic chemistry of polyunsaturated fatty acid and sterol peroxidation. Porter NA (2013) J Org Chem 78: 3511-24 Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndrome. Korade Z, Xu L, Shelton R, Porter NA (2010) J Lipid Res 51: 3259-69 Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome. Xu L, Liu W, Sheflin LG, Fliesler SJ, Porter NA (2011) J Lipid Res 52: 1810-20 Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells. Xu L, Korade Z, Rosado DA, Mirnics K, Porter NA (2013) J Lipid Res 54: 1135-43 Probing lipid-protein adduction with alkynyl surrogates: application to Smith-Lemli-Opitz syndrome. Windsor K, Genaro-Mattos TC, Kim HY, Liu W, Tallman KA, Miyamoto S, Korade Z, Porter NA (2013) J Lipid Res 54: 2842-50 An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome. Xu L, Korade Z, Rosado JDA, Liu W, Lamberson CR, Porter NA (2011) J Lipid Res 52: 1222-1233 A highly sensitive method for analysis of 7-dehydrocholesterol for the study of Smith-Lemli-Opitz syndrome. Liu W, Xu L, Lamberson C, Haas D, Korade Z, Porter NA (2014) J Lipid Res 55: 329-37 Assays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patients. Liu W, Xu L, Lamberson CR, Merkens LS, Steiner RD, Elias ER, Haas D, Porter NA (2013) J Lipid Res 54: 244-53 Oxidation of 7-dehydrocholesterol and desmosterol by human cytochrome P450 46A1. Goyal S, Xiao Y, Porter NA, Xu L, Guengerich FP (2014) J Lipid Res 55: 1933-43 On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO. Björkhem I, Diczfalusy U, Lövgren-Sandblom A, Starck L, Jonsson M, Tallman K, Schirmer H, Ousager LB, Crick PJ, Wang Y, Griffiths WJ, Guengerich FP (2014) J Lipid Res 55: 1165-72 Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndrome. Korade Z, Xu L, Mirnics K, Porter NA (2013) J Inherit Metab Dis 36: 113-22
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.